Top 5 Liver Cancer treatment startups

Sep 18, 2024 | By Jason Kwon

These startups develop new liver cancer treatments using such technologies as AI-powered MRI, liver biopsy, targeted therapy, immunotherapy, radiofrequency ablation, transarterial chemoembolization
1
Country: USA | Funding: $223.9M
Senti is using the latest techniques in the fields to build the future of gene and cell-based therapies. Senti’s proprietary synthetic biology platform provides fundamental advantages for therapeutics development.
2
Country: USA | Funding: $218.5M
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
3
Country: Switzerland | Funding: $184M
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
4
Country: Germany | Funding: $40K
The TheraBionic P1 medical device is indicated for the systemic treatment of advanced hepatocellular carcinoma with or without metastases. It emits low levels of radiofrequency electromagnetic fields, which block the growth of tumor cells and do not affect the growth of normal cells.
5
Country: Sweden | Funding: €71.4K
Our mission is to bring value to every patient by maximizing the capacity of some of the most effective medicines known and make them even better. Our areas of expertise are brain cancer, liver cancer and pneumonia. We have developed ways to treat these diseases much more effectively with our drug delivery system.
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Before that, he co-founded a startup consulting business for emerging entrepreneurial hubs in Asia. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, watching movie trailers, traveling to places where he can't get cell service. You can contact Jason at jaskwon(at)medicalstartups(dot)com